Equity researches at JPMorgan Chase downgraded payer Anthem’s stock from an “overweight” rating to a “neutral” rating Monday, according to Community Financial News. The downgrade means Anthem stock is ...
A stock’s earnings surprise track helps investors get an idea about its performance in the previous quarters. Anthem’s bottom line managed to beat estimates in three of the trailing four quarters, ...
Indianapolis-based Anthem is planning several moves following its failed $54 billion merger attempt with Bloomfield, Conn.-based Cigna, according to an Indianapolis Business Journal report. Here are ...
Hosted on MSN
Anthem Biosciences IPO listing date today. GMP, analysts signal strong debut of shares in stock market today
Anthem Biosciences IPO Listing: Anthem Biosciences shares are set to make their debut in the Indian stock market today. The initial public offering (IPO) of specialized fermentation-based APIs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results